Lakefront Biotherapeutics NV 20-F for FY2020
Lakefront Biotherapeutics NV (LKFT)
20-F
2021-03-25
For: 2020-12-31
View Original
Added on
April 04, 2026
About this 20-F
Lakefront Biotherapeutics NV filed this 20-F on March 25, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 478.05M EUR
- down 42.7% from 834.9M EUR a year earlier
- Net loss
- 305.44M EUR
- compared with net income of 149.85M EUR a year earlier
- Diluted EPS
- -4.69 EUR
- compared with 2.49 EUR a year earlier